Advertisement
February 1, 20265 min readMedicines & Drugs

Apixaban API: Direct Oral Anticoagulant Uses and Specifications

Apixaban is a widely used direct oral anticoagulant. This overview highlights its clinical uses, mechanism of action, and important quality parameters at the API stage.

Apixaban API: Direct Oral Anticoagulant Uses and Specifications

Overview of Apixaban API

Apixaban is an oral, direct factor Xa inhibitor used as an anticoagulant for stroke prevention in non‑valvular atrial fibrillation and for the treatment and prevention of venous thromboembolism (VTE). As an API, Apixaban is supplied for high‑precision oral tablet formulations.

Clinical Uses

  • Prevention of stroke and systemic embolism in patients with non‑valvular atrial fibrillation
  • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
  • Prevention of recurrent DVT and PE
  • Prophylaxis of VTE after hip or knee replacement surgery

Mechanism of Action

Apixaban selectively and reversibly inhibits free and clot‑bound factor Xa, thereby reducing thrombin generation and thrombus formation. It does not require routine INR monitoring in most patients, which has contributed to its widespread adoption.

Quality and Regulatory Requirements

For regulated markets, Apixaban API is expected to comply with stringent specifications for assay, purity, stereochemical integrity, residual solvents, and particle size. Robust analytical methods, ICH‑compliant stability data, and DMF/CEP support are essential components of a reliable supply chain.

Advertisement

Share this article:

V

About Vubrix Pharma Team

Our team of pharmacists and medical writers share accurate, easy-to-understand medicine information for healthcare professionals and patients.

Advertisement